Lumos Pharma Delays Data Readout From Pediatric Growth Hormone Deficiency Trial To 2H Of 2023Benzinga • 07/21/21
Lumos Pharma Announces OraGrowtH212 Trial of LUM-201 in PGHD Is Open for EnrollmentGlobeNewsWire • 06/28/21
Lumos Pharma, Inc. (LUMO) CEO Rick Hawkins on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/06/21
Lumos Pharma Reports First Quarter 2021 Financial Results and Provides Clinical and Corporate UpdatesGlobeNewsWire • 05/05/21
Lumos Pharma to Report First Quarter 2021 Financial Results and Host Conference Call on May 5, 2021GlobeNewsWire • 04/28/21
Lumos Pharma Announces Retirement of Carl Langren and Names Lori Lawley Chief Financial Officer in Planned SuccessionGlobeNewsWire • 04/20/21
Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone DeficiencyGlobeNewsWire • 04/14/21
Data Presented at ENDO 2021 Differentiate LUM-201 from Standard Growth Hormone Secretagogues and Further Support LUM-201's Potential as a Therapeutic for Pediatric Growth Hormone DeficiencyGlobeNewsWire • 03/20/21
Lumos Pharma's (LUMO) CEO Rick Hawkins on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/10/21
Lumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHDGlobeNewsWire • 03/09/21
Lumos Pharma to Present Poster Demonstrating Greater GH Response to LUM-201 than to Standard GH Secretagogues in PGHD at the Endocrine Society (ENDO) 2021 Annual MeetingGlobeNewsWire • 03/02/21
Will Lumos Pharma (LUMO) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 03/02/21
Lumos Pharma to Report Full Year 2020 Financial Results and Host Conference Call on March 9, 2021GlobeNewsWire • 02/22/21
Lumos Pharma to Participate in the H.C. Wainwright BioConnect 2021 ConferenceGlobeNewsWire • 12/18/20
Lumos Pharma, Inc. (LUMO) CEO Rick Hawkins on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/11/20
Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial ResultsGlobeNewsWire • 11/10/20
Lumos Pharma (LUMO) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 11/03/20